Pharmaceutical giant Pfizer (PFE) has named company veteran Chris Boshoff its chief of research and development (R&D) as it ...
One of Australia's leading clinician scientists and founder of national genomic cancer medicine centre, Omico, Professor David Thomas, received the ...
One of Australia’s leading clinician scientists and founder of national genomic cancer medicine centre, Omico, Professor David Thomas, received the state’s highest accolade for cancer research at the ...
A chemotherapy-free regimen of neoadjuvant nivolumab (Opdivo) with or without ipilimumab (Yervoy) induced immune activation ...
BRITISH pharmaceutical giant AstraZeneca is investing US$3.5bn into expanding its research and development (R&D) operations ...
Merck (MRK) stock gains as its subcutaneously delivered pembrolizumab meets key goals in Phase 3 trial against intravenous ...
We congratulate the eleven researchers at the Department of Cell and Molecular Biology who have been awarded grants from the ...
US pharma giant Merck & Co (NYSE: MRK) today announced positive top-line results from the pivotal Phase III MK-3475A-D77 ...
Upadacitinib 15 mg plus a 26-week GC taper outperformed placebo in combination with a 52-week GC taper for the treatment of ...
Astrazeneca's share price fall was triggered by ongoing investigations in China and disappointing trial data for its cancer ...
They gave me some literature to read about the hallmarks of cancer and some stuff on small cell lung cancer, and we still ...
Though the cell map is still in its early days, it is already giving scientists a lot of valuable information. It could ...